Workflow
高级中间体
icon
Search documents
这家公司持续亏损!昊帆生物却要溢价250%收购!
IPO日报· 2025-07-07 12:08
Core Viewpoint - Suzhou Haofan Bio Co., Ltd. plans to acquire 100% equity of Hangzhou Foster Pharmaceutical Co., Ltd. for 160 million yuan, aiming to enhance its production capacity and product offerings despite the target company's current losses [1][4][11]. Group 1: Acquisition Details - The acquisition will occur in two phases, with the first phase granting Haofan Bio 85% equity, making it the controlling shareholder [1]. - The total transaction price is set at 160 million yuan, based on an asset-based valuation of 97.02 million yuan and a revenue-based valuation of 161.81 million yuan, indicating a significant premium [5][6]. Group 2: Financial Performance of Target Company - Hangzhou Foster reported revenues of 203.69 million yuan and 26.18 million yuan for 2024 and Q1 2025, respectively, with net losses of 28.44 million yuan and 8.44 million yuan [3][4]. - As of March 31, 2025, Hangzhou Foster's total assets were 268.74 million yuan, with total liabilities of 222.71 million yuan, resulting in a net asset value of 46.03 million yuan [3]. Group 3: Strategic Rationale - The acquisition is expected to allow Haofan Bio to leverage Hangzhou Foster's excess production capacity and certifications, enhancing operational efficiency and market competitiveness [12]. - The move aligns with Haofan Bio's strategy to expand its product structure and create new business and profit growth points, especially as its current production capacity is insufficient to meet demand [11][12].
啥情况?高位人气股跌停:6500万股地板价疯狂出逃…
Xin Lang Cai Jing· 2025-06-11 09:48
转自:问理财网 图片来源:水云千帆 对于近期公共传媒报道了公司涉及生产氯虫苯甲酰胺的相关内容,联化科技表示,公司目前以CDMO业 务模式为客户提供氯虫苯甲酰胺的高级中间体,不直接生产氯虫苯甲酰胺。公司与该客户是长期合作伙 伴关系,合作产品数量较多。 截至目前,公司尚未收到该客户关于相关产品需求增加的通知。因此,相关事项对公司整体影响有限, 请广大投资者理性看待,注意投资风险。 资料显示,联化科技股份有限公司始建于1985年,其前身是黄岩县城关联合化工厂,公司于2008年6月 19日在深圳证券交易所成功挂牌上市。目前,公司主营工业业务分为植保、医药、功能化学品和设备与 工程服务板块。 业绩方面,2022年至2024年公司实现营收分别为78.65亿元、64.42亿元、56.77亿元,同期实现净利润分 别为6.97亿元、-4.65亿元、1.03亿元…… 啥情况?翻倍牛股录得跌停板,6500万股地板价疯狂出逃…… 6月11日,联化科技(002250)跌停,股价报收13.32元,当日成交220.9万手,成交金额30.8亿元;其中以 跌停价成交超65万手…… 数据显示,在5月28日至6月10日期间,联化科技股价表现相当活 ...
晚间公告丨6月8日这些公告有看头
第一财经· 2025-06-08 11:48
2025.06. 08 6月8日晚间,沪深两市多家上市公司发布公告,以下是第一财经对一些重要公告的汇总,供投资者 参考。 【品大事】 中颖电子:控股股东筹划控制权变更 股票6月9日起停牌 中颖电子(300327)公告,公司控股股东威朗国际集团有限公司正在筹划公司控制权变更相关事宜, 该事项可能导致公司控股股东及实际控制人发生变更。经公司向深圳证券交易所申请,公司股票自 2025年6月9日开市起停牌,预计停牌时间不超过2个交易日。本次交易事项能否最终实施完成及实 施结果尚存在不确定性。 ST路通:收到江苏证监局行政监管措施决定书 益生股份(002458)公告,5月白羽肉鸡苗销售数量5660.97万只,销售收入1.74亿元,同比变动分 别为11.35%、-11.21%,环比变动分别为15.69%、23.05%。益生909小型白羽肉鸡苗销售数量 719.86万只,销售收入633.61万元,同比变动分别为-8.85%、-36.23%,环比变动分别为 4.95%、1.25%。5月种猪销售数量10849头,销售收入2572.29万元,同比变动分别为 207.08%、196.81%,环比变动分别为221.17%、170.2 ...
联化科技: 关于股票交易异常波动及严重异常波动的公告
Zheng Quan Zhi Xing· 2025-06-08 08:18
Core Viewpoint - The stock price of Lianhua Technology (stock code: 002250) has experienced significant fluctuations, with a cumulative price deviation exceeding 20% over three consecutive trading days, indicating abnormal trading activity [1][2]. Group 1: Stock Trading Fluctuations - The stock price of Lianhua Technology has shown a cumulative price deviation of over 20% from June 4 to June 6, 2025, qualifying as abnormal trading activity [2]. - Over a ten-day period from May 23 to June 6, 2025, the stock price has also shown significant fluctuations, with a cumulative deviation indicating severe abnormal trading [2][3]. Group 2: Company Operations and Client Relationships - Lianhua Technology operates under a CDMO business model, providing advanced intermediates for chlorantraniliprole, without directly producing the chemical [1][2]. - The company has a long-term partnership with a client, having signed a framework agreement for customized processing of advanced intermediates, with a pricing model based on cost-plus [1][2]. - As of now, the company has not received any notifications from the client regarding an increase in product demand, suggesting limited impact on overall operations [1][2]. Group 3: Financial Metrics - The company's current price-to-earnings (P/E) ratio stands at 113.10, significantly higher than the industry average P/E ratio of 32.51 for the "15101040 Pesticides" sector [1][3].
盘前情报丨中办、国办印发《关于健全资源环境要素市场化配置体系的意见》;美国上诉法院暂时恢复实施特朗普政府关税政策
昨日A股 5月29日,A股三大指数集体上涨,截至收盘,沪指涨0.70%,深成指涨1.24%,创业板指涨1.37%,北证 50指数涨2.73%。全市场成交额12134亿元,较上日放量1795亿元。全市场超4400只个股上涨。板块题 材上,无人驾驶、创新药、移动支付板块领涨;贵金属、食品板块跌幅居前。 盘面上,移动支付概念领涨,无人驾驶概念掀涨停潮,可控核聚变概念反复活跃。创新药概念涨幅居 前,黄金概念跌幅居前。 | 名称 最新点位 | 涨跌幅 | | --- | --- | | 上证指数 3363.45 | +23.52(0.7%) | | 深证指数 10127.2 | +123.93(1.24%) | | 2012.55 创业板指 | +27.17(1.37%) | | 日期:5月29日 制图:21投资通 | | 隔夜外盘 纽约股市三大股指5月29日上涨。截至当天收盘,道琼斯工业平均指数比前一交易日上涨117.03点,收 于42215.73点,涨幅为0.28%;标准普尔500种股票指数上涨23.62点,收于5912.17点,涨幅为0.40%;纳 斯达克综合指数上涨74.93点,收于19175.87点,涨幅为0 ...
5月30日早间新闻精选
news flash· 2025-05-30 00:13
智通财经5月30日早间新闻精选 1、中办、国办印发《关于健全资源环境要素市场化配置体系的意见》。其中提出,严格用水总量和强 度双控,加强排污权与排污许可等制度衔接。 2、据报道,美国政府已实质性切断了部分美国企业向中国出售半导体设计软件的渠道,受影响企业包 括Cadence、Synopsys及Siemens EDA。对于美方滥用出口管制措施,中国商务部此前表示,倘若美方一 意孤行,继续实质性损害中方利益,中方必将采取坚决措施,维护自身正当权益。 3、美国联邦上诉法院29日批准了特朗普政府的请求,暂时中止此前一家下级法院禁止执行美政府多个 关税行政令的裁决。 4、国务院国资委主任张玉卓到中国汽车技术研究中心有限公司调研时指出,努力突破和掌握更多关键 核心技术,夯实产业技术底座,发挥行业标准引领作用,助力民族汽车品牌更好"走出去"。 7、广西广电公告,拟将广电科技100%股权与控股股东所持交科集团51%股权置换;双林股份公告,拟 定增募资不超15亿元;移为通信公告,拟1亿元设立全资子公司;品高股份公告,签订3.97亿元算力资 源服务合同。 8、光洋股份公告,终止购买银球科技100%股权等事项。 9、6连板尚纬股份 ...
A股公告精选 | 品高股份(688227.SH)子公司签下近4亿元算力服务合同
智通财经网· 2025-05-29 12:35
Group 1 - Pinggao Co., Ltd. signed a service contract worth 397 million yuan with Shenzhen Yuanmai Cloud Computing Technology Co., Ltd. for providing computing power resources, including equipment rental and software platform usage, with a contract period from August 1, 2025, to July 31, 2030 [1] - Yiwei Communication plans to invest 100 million yuan to establish a wholly-owned subsidiary, Shanghai Yiwei Intelligent Technology Development Co., Ltd., focusing on IoT technology research and AI application software development, aiming to enhance overall competitiveness [2] - Guangyang Co., Ltd. announced the termination of the planned acquisition of 100% equity in Yinqiu Technology, with its stock resuming trading on May 30, 2025, after being suspended since May 19, 2025 [3] Group 2 - ST Pioneer announced the removal of other risk warnings, changing its stock name to Pioneer New Materials, with trading resuming on June 3, 2025, after a one-day suspension [4] - Shuanglin Co., Ltd. plans to raise no more than 1.5 billion yuan through a private placement to fund projects related to rolling ball screws, joint modules, and high-precision CNC grinding machine expansion [5] - China State Construction obtained three major projects with a total value of 8.23 billion yuan [8]
联化科技: 关于股票交易异常波动的公告
Zheng Quan Zhi Xing· 2025-05-29 09:46
Group 1 - The company's stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices over three consecutive trading days (May 27, 28, and 29, 2025) [1] - The company operates under a CDMO business model, providing advanced intermediates of chlorantraniliprole to a long-term partner, with no notification of increased demand from this customer [1] - The company has not identified any significant undisclosed information in public media that could have impacted its stock price [1] Group 2 - The board confirmed that there are no undisclosed matters that should be reported according to the Shenzhen Stock Exchange listing rules, nor any related negotiations or agreements [2] - The company has not found any need to correct or supplement previously disclosed information [2]
联化科技:公司目前以CDMO业务模式为客户提供氯虫苯甲酰胺的高级中间体 产品仅向该客户出售
news flash· 2025-05-29 08:54
Core Viewpoint - The company, Lianhua Technology (002250), has announced that its stock trading has experienced unusual fluctuations, but the overall impact on the company is limited due to the nature of its business model and current operational status [1] Group 1: Business Model and Operations - The company operates under a CDMO (Contract Development and Manufacturing Organization) business model, providing advanced intermediates of chlorantraniliprole exclusively to a single client [1] - The pricing model for the products is based on a cost-plus approach, ensuring stable revenue from the client [1] - As of now, the company has not received any notification from the client regarding an increase in demand for the related products, indicating stable demand [1] Group 2: Market and External Factors - The company has not identified any significant undisclosed information that may have impacted its stock trading price, despite recent media reports [1] - The company's production and operational conditions remain normal, with no significant changes in the internal or external business environment [1]